🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 769.60 -1.1% NASDAQ 100: 728.95 -2.0% Dow Jones: 534.08 -0.5%

Topline Capital Management - Q2 2026 13F Filings

TO

Topline Capital Management, LLC

CIK: 0001792549
Address: California Santa Monica 544 Euclid Street
$385.69 M
Portfolio Value
36
Assets Held
Reporting Period: Q2 2026
Filing Status:
Active
Last Updated: 08/14/2026

Portfolio Summary (Q2 2026)

View Full Portfolio Analysis

Top Buys

Q2 2026
1. NPK National Presto Industries
+$4.03 M
2. ATRC Atricure
+$3.87 M
3. CERS Cerus Corporation
+$3.07 M
4. SIF Sifco Industries
+$833,274
5. ZVIA Zevia Pbc
+$699,041.79

Top Sells

Q2 2026
1. FRSH Freshworks
−$59.78 M
2. MITK Mitek Systems
−$30.56 M
3. S Sentinelone
−$28.03 M
4. MNDY Mondaycom
−$25.15 M
5. NUTX Nutex Health
−$23.25 M

Asset Allocation

Stocks/ETFs
-36.28%
$385.69 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Topline Capital Management Q2 2026 Filing Summary

Topline Capital Management, LLC filed its 13F report for Q2 2026 on August 14, 2026. The portfolio totaled 385.69 M reflecting a -36.28% change from the prior quarter, spanning 36 assets. The top 10 holdings comprised 80.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 9 new positions and 16 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Topline Capital Management’s Q2 2026 Filing

Topline Capital Management submitted their Form 13F-HR for the Q2 2026 period on 08/14/2026. This was the only submission for the quarter.

In the Q2 2026 filing, Topline Capital Management reported a managed portfolio value of 385.69 M, consisting of 36 individual positions.

This page displays the raw filing documents. To see which stocks Topline Capital Management bought or sold during Q2 2026, please visit Topline Capital Management's Portfolio Analysis page.